Potentiation of Type I interferon signaling leads to in vivo efficacy achieved with combination of chemotherapy and the PARP7 inhibitor RBN-2397Kaiko Kunii, Jeff J. Song, Danielle Zimmerman, Chang Liu,Kristy G. Kuplast-Barr, Jonathan J. Novak,Sunaina P. Nayak,Joseph M. Gozgit,Melissa M. Vasbinder,Kristen McEachern,Kevin W. Kuntz,Heike Keilhack,Jennifer R. MolinaCANCER RESEARCH(2023)引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要